SS&C Technologies Holdings Inc

SS&C Technologies Holdings Inc

SSNC

Get informed when a big investor buys or sells

+ Follow
Market Cap$15.76B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
SS&C Technologies Holdings IncSS&C Technologies Holdings Inc19.51.65%12%2.50.1

Earnings Call Q4 2025

February 5, 2026 - AI Summary

Strong Financial Performance: SS&C Technologies reported record adjusted revenue of $1.655 billion in Q4 2025, an 8% increase year-over-year (YOY), and adjusted diluted earnings per share (EPS) of $1.69, reflecting an 18% increase. Adjusted consolidated EBITDA reached a record $651 million, marking a 9% increase with an EBITDA margin of 39.3%. Cash from operating activities was $1.745 billion, up 26% YOY.
Dividends and Share Buybacks: In Q4 2025, the company returned $384 million to shareholders, which included $319 million in share repurchases (3.7 million shares at an average price of $85.81) and $66 million in dividends. Over the full year of 2025, SS&C repurchased over $1 billion worth of shares, which provides a strong signal of management's confidence in the company's ongoing profitability and cash flow generation.
2026 Guidance: The company provided optimistic guidance for 2026, projecting revenue of $1.608 billion to $1.648 billion, indicating continued growth potential with 5% organic growth at the midpoint. Adjusted net income is expected to be between $404 million to $420 million with adjusted diluted EPS guidance ranging from $1.62 to $1.68, reflecting about 12% growth at the midpoint.

Exclusive for Stockcircle Pro members

Sign upSign Up
$94.20

Target Price by Analysts

42.3% upsideSS&C Technologies Holdings Target Price DetailsTarget Price
$95.42

Current Fair Value

44.2% upside

Undervalued by 44.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$15.76 Billion
Enterprise Value$16.21 Billion
Dividend Yield$1.08 (1.65%)
Earnings per Share$3.26
Beta1.1
Outstanding Shares241,500,000

Return

Return on Equity11.74%ROE
Return on Assets3.98%
Return on Invested Capital9.51%

Valuation & Multiples

P/E Ratio19.5P/E Ratio
PEG317.14PEG
Price to Sales2.55Price to Sales
Price to Book Ratio2.36Price to Book Ratio
Enterprise Value to Revenue2.53
Enterprise Value to EBIT11.03
Enterprise Value to Net Income20
Total Debt to Enterprise0.05
Debt to Equity0.13Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 23, 2026
EPS Estimate
$1.66
Average shareholder expectation
Revenue Estimate
$1.63 B
Average shareholder expectation

Next Earnings Call

Expected Date
July 22, 2026
EPS Estimate
$1.68
Average shareholder expectation
Revenue Estimate
$1.66 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.7936▲ 76.20%
Total Calls497,500▲ 62.00%
Total Puts394,800▲ 3970.10%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %82.05%▼ 2.58%
Total Invested$13.56B▼ 25.13%
Investors Holding728▼ 37.00%

ESG Score

No data

About SS&C Technologies Holdings Inc

22,600 employees
CEO: William Stone

SS&C is a global provider of services and software for the Unancial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has o ces around the world. Some 18,000 Enancial services and hea...

Relevant Senate Committees

Finance

This powerful committee controls taxation and entitlement spending. Its tax policy decisions directly affect SS&C's corporate valuation and profitability, while its influence on Medicare pricing impacts SS&C's healthcare industry clients.

Agriculture, Nutrition, and Forestry

This committee oversees the CFTC, which regulates the derivatives/futures market and is a key player in defining cryptocurrencies as digital commodities. This directly impacts the market environment for many of SS&C's financial services clients.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA and NIH, significantly impacting SS&C's healthcare industry clients (e.g., biotech, pharma). It also influences labor laws and costs, which affect SS&C's operational expenses.

Banking, Housing, and Urban Affairs

This committee directly regulates the financial system (Fed, SEC), which is SS&C's primary client base. Changes in bank capital requirements, cryptocurrency regulation, or other financial laws directly impact the demand for SS&C's compliance and operational software.